Resource Center
Resource Center
The white paper published today shows that thermal ablation, a portable and effective tool for treating cervical precancer, has the potential to substantially expand access in low- and middle-income countries where almost 90 percent of deaths occur.
Read more
Our monthly check-in with staff from around the world. Learn more about the people who work at CHAI.
Read more
On Nov. 15, 2021 CHAI, MedAccess, and SD Biosensor announced a partnership to increase access to rapid diagnostic tests for syphilis and HIV.
Read more
This report helps donors and buyers in public health better understand the offerings of respiratory equipment suppliers based in sub-Saharan Africa.
Read more
The report provides market intelligence on hepatitis C diagnostics and drugs in low- and middle-income countries and covers preliminary insights into the hepatitis B market.
Read more
The expanded partnership will increase access to leading-edge cancer treatments in low- and middle-income countries including biologics and hormonal therapies.
Read more
In 2019, CHAI launched our cervical cancer program with support from Unitaid. We partnered with governments in seven low-and-middle income countries to scale up safe, effective, and affordable pre-cancer screening and treatment technologies and assist partner governments in achieving global cervical cancer elimination targets, aiming to reduce the rate of premature mortality from the disease by a third.
Read more
A new article published in BMJ Global Health details results of five years of CHAI support to governments as they initiate and scale up hepatitis C programs across seven low- and middle-income countries.
Read more
As the world grapples with COVID-19, the pandemic is also highlighting and deepening pre-existing inequalities. This year the International Day of Persons with Disabilities reflects that with the theme “building back better: toward a disability-inclusive, accessible and sustainable post COVID-19 world”. People with disabilities are among the most excluded and hardest hit by this crisis...
Read more
The report looks at the complex, ever-changing antiretroviral and diagnostic markets in low- and middle-income countries based on aggregated market intelligence from our programmatic work in over 30 countries.
Read more